UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Helixmith picks CRO for US trial of diabetes drug
Helixmith said Thursday that it has chosen PRA Health Sciences as the key p...
by Shim Hyun-tai
|
2020-03-26 14:57
라인
2 drugmakers react differently to coronavirus pandemic
With the new coronavirus hitting the globe more extensively, a manufacturer...
by Kim Yun-mi
|
2020-03-26 13:36
라인
SK Chemicals' upgraded Rinexin wins marketing approval
SK Chemicals said Wednesday that its sustained-release anti-platelet compou...
by Shim Hyun-tai
|
2020-03-25 17:52
라인
Boryung to launch 1st generic treatment for secondary hyperparathyroidism
Boryeong Pharmaceutical said Wednesday that it would release the secondary ...
by Shim Hyun-tai
|
2020-03-25 16:25
라인
Price negotiations begin for breast cancer combo drugs
Drugmakers and the government will start talks this week to negotiate price...
by Kim Yun-mi
|
2020-03-25 16:25
라인
Abbvie’s leukemia drug to get insurance benefits
AbbVie said Wednesday that the Ministry of Health and Welfare has approved ...
by Shim Hyun-tai
|
2020-03-25 16:24
라인
LegoChem Pharma has rush of export requests for malaria treatment
LegoChem Pharmaceutical said that it has recently received a large number o...
by Lee Han-soo
|
2020-03-24 12:06
라인
Celltrion speeds up development of COVID-19 treatment
Celltrion said Monday that has successfully secured 300 types of antibodies...
by Shim Hyun-tai
|
2020-03-23 18:11
라인
Institut Pasteur Korea finds Alvesco effective in treating COVID-19
Institute Pasteur Korea (IPK) said Monday that it has confirmed the efficac...
by Shim Hyun-tai
|
2020-03-23 17:45
라인
Drug sales reps turning to digital promotions
The outbreak of the new coronavirus (COVID-19) has taken an extensive toll ...
by Kim Yun-mi
|
2020-03-23 16:15
라인
SK Bioscience starts animal trial of COVID-19 vaccine
SK Bioscience said that it has succeeded in discovering a vaccine candidate...
by Lee Han-soo
|
2020-03-23 11:52
라인
Macrogen reports profit drop in 2019
Macrogen said that it posted 122.3 billion won ($97.6 million) in sales las...
by Lee Han-soo
|
2020-03-20 12:34
라인
Peptron’s trial of Parkinson’s disease treatment in full swing
Peptron, a company specializing in R&D of drugs with long-term efficacy, sa...
by Shim Hyun-tai
|
2020-03-20 11:31
라인
Novo Nordisk's Saxenda remains world’s top obesity treatment
Novo Nordisk Pharma Korea announced Thursday that Saxenda (ingredient: lira...
by Shim Hyun-tai
|
2020-03-19 17:59
라인
DM Bio, GI Innovation tie up on allergy treatment candidate
DM Bio said that it has made a contract development and manufacture organiz...
by Lee Han-soo
|
2020-03-19 15:54
라인
AbClon wins US patent for autoimmune bispecific antibody
AbClon said that it has succeeded in obtaining a U.S. patent for the AM201,...
by Lee Han-soo
|
2020-03-19 15:45
라인
Theragen ETEX to develop treatment candidate for COVID-19
Theragen ETEX said that it has found multiple drug candidates for treating ...
by Lee Han-soo
|
2020-03-18 17:41
라인
Kainos Medicine asks FDA to meet on Parkinsonism treatment
Kainos Medicine said that it has made a request to the U.S. Food and Drug A...
by Lee Han-soo
|
2020-03-18 17:07
라인
Alteogen ends p-1 clinical trial of breast cancer treatment
Alteogen said Tuesday that it has completed the phase 1 clinical trials of ...
by Shim Hyun-tai
|
2020-03-17 18:16
라인
HIV combo drug Dovato scores local nod
GSK’s Dovato (ingredient: dolutegravir/lamivudine), the first two-drug regi...
by Kim Yun-mi
|
2020-03-17 15:58
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top